Receptors, Antigen, T-Cell
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D011948
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.543.750.705.816.824 
						 | 
					
					
						| Concept/Terms | 
						
							Receptors, Antigen, T-Cell- Receptors, Antigen, T-Cell
 - T-Cell Antigen Receptor
 - Antigen Receptor, T-Cell
 - Receptor, T-Cell Antigen
 - T Cell Antigen Receptor
 - T-Cell Receptors
 - Receptors, T-Cell
 - T Cell Receptors
 - T-Cell Receptor
 - Receptor, T-Cell
 - T Cell Receptor
 - Receptors, T-Cell Antigen
 - Receptors, T Cell Antigen
 - T-Cell Antigen Receptors
 - Antigen Receptors, T-Cell
 - Antigen Receptors, T Cell
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".
				
					
						- Receptors, Antigen, T-Cell
 - Complementarity Determining Regions
 - Receptor-CD3 Complex, Antigen, T-Cell
 - Receptors, Antigen, T-Cell, alpha-beta
 - Receptors, Antigen, T-Cell, gamma-delta
 
					
				 
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in this website by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 1 | 1 | 2 | 
| 1996 | 1 | 0 | 1 | 
| 1998 | 2 | 1 | 3 | 
| 1999 | 0 | 1 | 1 | 
| 2000 | 1 | 0 | 1 | 
| 2001 | 1 | 4 | 5 | 
| 2002 | 2 | 6 | 8 | 
| 2003 | 2 | 1 | 3 | 
| 2004 | 2 | 2 | 4 | 
| 2005 | 1 | 4 | 5 | 
| 2006 | 3 | 0 | 3 | 
| 2007 | 1 | 3 | 4 | 
| 2008 | 0 | 1 | 1 | 
| 2009 | 2 | 2 | 4 | 
| 2010 | 3 | 3 | 6 | 
| 2011 | 4 | 1 | 5 | 
| 2012 | 1 | 1 | 2 | 
| 2013 | 5 | 4 | 9 | 
| 2014 | 5 | 4 | 9 | 
| 2015 | 4 | 6 | 10 | 
| 2016 | 6 | 2 | 8 | 
| 2017 | 16 | 8 | 24 | 
| 2018 | 10 | 3 | 13 | 
| 2019 | 9 | 6 | 15 | 
| 2020 | 11 | 8 | 19 | 
| 2021 | 7 | 4 | 11 | 
| 2022 | 1 | 13 | 14 | 
| 2023 | 2 | 14 | 16 | 
| 2024 | 4 | 6 | 10 | 
| 2025 | 5 | 4 | 9 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.
						
					
								- 
								
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Adv. 2025 Nov 11; 9(21):5460-5472.
															
								 
							
								- 
								
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood Adv. 2025 Nov 11; 9(21):5489-5500.
															
								 
							
								- 
								
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Adv. 2025 Oct 28; 9(20):5249-5262.
															
								 
							
								- 
								
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel. Blood Adv. 2025 Oct 14; 9(19):5070-5084.
															
								 
							
								- 
								
Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy. Cell Rep Med. 2025 Sep 16; 6(9):102324.
															
								 
							
								- 
								
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. Front Immunol. 2025; 16:1618404.
															
								 
							
								- 
								
The T cell receptor landscape of childhood brain tumors. Sci Transl Med. 2025 Mar 19; 17(790):eadp0675.
															
								 
							
								- 
								
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Nat Med. 2025 Apr; 31(4):1125-1129.
															
								 
							
								- 
								
Gene editing of CD3 epsilon to redirect regulatory T?cells for adoptive T?cell transfer. Mol Ther. 2025 Mar 05; 33(3):997-1013.
															
								 
							
								- 
								
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 03; 31(3):529-542.